New cancer clinical trial: A Preliminary Clinical Study on the Pharmacokinetics, Safety and Immunogenicity of CDP1 in Patients With Advanced CRC

Published on: April 09, 2018 at 12:00PM
Condition:   Colorectal Cancer
Interventions:   Drug: anti-EGFR monoclonal antibody;   Drug: Cetuximab injection
Sponsors:   Dragonboat Biopharmaceutical Company Limited;   Shanghai East Hospital
Not yet recruiting
https://ift.tt/2GJmqnk